CALCULATE YOUR SIP RETURNS

Stocks/Share Market - Angel One

Sun Pharma and Takeda Collaborate To Launch Gastrointestinal Drug in India

Sun Pharma and Takeda Collaborate To Launch Gastrointestinal Drug in India

21 June 2024

Sun Pharmaceutical Industries Ltd., has announced a partnership with Takeda Pharmaceutical Company Ltd. This collaboration aims to introduce an innovative gastrointestinal (GI) drug in the Indian market. The memorandum of understanding (MoU) between the two companies marks a pivotal step in increasing the availability of advanced treatments for gastrointestinal conditions in India. Collaboration Details Under …

RR Kabel MD Announces Rs.500 Cr Investment for FY25 Product Development

RR Kabel MD Announces Rs.500 Cr Investment for FY25 Product Development

21 June 2024

In a recent interview, RR Kabel’s promotor and Managing Director, Shreegopal Kabra, discussed various topics related to the company’s business strategies, product developments, and regulatory concerns. RR Kabel was listed in 2018 and since then the company hasn’t seen many internal changes but the listing did make it easier to raise funds for the company, …

Top 3 Performing Stocks of the Week: Here’s Why They Outperformed

Top 3 Performing Stocks of the Week: Here’s Why They Outperformed

14 June 2024

The week was marked by a continuous rise in the Nifty, with prices reaching new highs throughout. However, traders encountered difficulties trading within the major indices due to slow intraday movements. On Friday, Nifty opened on a positive note but lacked consistent buying momentum, staying within a tight 50-point range and ending with a 0.29% …

The Top 3 Wealth Destroyers of 2024: Lessons for Investors

The Top 3 Wealth Destroyers of 2024: Lessons for Investors

14 June 2024

In 2024, several companies have significantly eroded investor wealth, causing substantial financial pain and disappointment. Here, we highlight the top three wealth destroyers: Zee Entertainment, Syrma SGS Technology Ltd, and One 97 Communications Ltd (Paytm). We delve into the reasons behind their declining stock prices and the critical lessons investors can learn from these developments. …

Sun Pharma Advances MM-II for Osteoarthritis Relief

Sun Pharma Advances MM-II for Osteoarthritis Relief

14 June 2024

On June 14, 2024, Sun Pharma and Moebius Medical revealed new findings at EULAR 2024. They shared data showing that patients with symptomatic knee osteoarthritis continued to experience significant pain relief up to 26 weeks after receiving injections of MM-II. These results come from a Phase 2b clinical trial (NCT04506463) that included randomised and controlled …

Minda Corporation Forms Joint Venture for Automotive Sunroof Solutions

Minda Corporation Forms Joint Venture for Automotive Sunroof Solutions

14 June 2024

On June 14, 2024, Minda Corporation signed a Joint Venture Agreement with HSIN CHONG MACHINERY WORKS CO., LTD (HCMF) under SEBI regulations. The agreement established a new entity manufacturing Automotive Sunroof Solutions and Closure Technology Products for passenger cars. Minda Corporation and HCMF will hold a 50% stake in the joint venture company. The proposed …

Titagarh Rail Systems Starts Trainset Production for Bengaluru Metro’s Yellow Line

Titagarh Rail Systems Starts Trainset Production for Bengaluru Metro’s Yellow Line

14 June 2024

On June 14, 2024, Titagarh Rail Systems Limited (TRSL), a leading Indian train manufacturer, started producing trainsets under a contract with China Railway Rolling Stock Corporation (CRRC). These trainsets are for the Bangalore Metro Rail Corporation Limited’s (BMRCL) Phase 2 Yellow Line project. This achievement highlights Titagarh’s important role in improving urban transportation in India. …

Zydus Lifesciences Scores USFDA Nod for Hypertension Treatment Medication

Zydus Lifesciences Scores USFDA Nod for Hypertension Treatment Medication

14 June 2024

Zydus Lifesciences Limited (Zydus), a leading Indian multinational pharmaceutical company, announced a significant development in its quest to expand its global reach. The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil and Chlorthalidone Tablets, 40 mg/12.5 mg and 40 mg/25 mg, under the brand name …

Jindal Stainless Completes Acquisition of Chromeni Steels

Jindal Stainless Completes Acquisition of Chromeni Steels

14 June 2024

On June 14, 2024, Jindal Stainless Limited announced to the stock exchanges its acquisition of Chromeni Steels Private Limited (CSPL). This move follows earlier disclosures made on May 1, 2024, and June 4, 2024, in which Jindal Stainless Limited detailed its acquisition of a 54% equity stake in Chromeni Steels Private Limited through the purchase …

Lupin’s Nagpur Injectable Facility Clears U.S. FDA Inspection with Zero Observations

Lupin’s Nagpur Injectable Facility Clears U.S. FDA Inspection with Zero Observations

14 June 2024

On June 14, 2024, Lupin Limited, a leading global pharmaceutical company, announced in a stock exchange filing that its Injectable facility located in Nagpur, India, underwent a thorough inspection by the United States Food and Drug Administration (U.S. FDA). The inspection, conducted from June 10 to June 13, 2024, concluded with a favourable outcome as …

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Open Free Demat Account!
Join our 3 Cr+ happy customers